The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
nab-Paclitaxel mechanisms of action and delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
Shepherd, F. A., Dancey, J., Ramlau, R., Mattson, K., Gralla, R., O’Rourke, M., Levitan, N., Gressot, L., Vincent, M., Burkes, R., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2095 · Cited by 2,181
Peters, T. (1985) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60065-0 · Cited by 2,181
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,175
O’Shaughnessy, J., Miles, D., Vukelja, S., Moiseyenko, V., Ayoub, J.-P., Cervantes, G., Fumoleau, P., Jones, S., Lui, W.-Y., Mauriac, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.002 · Cited by 1,081
Von Hoff, D. D., Ramanathan, R. K., Borad, M. J., Laheru, D. A., Smith, L. S., Wood, T. E., Korn, R. L., Desai, N., Trieu, V., Iglesias, J. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.5742 · Cited by 1,044
Adjuvant Docetaxel for Node-Positive Breast Cancer
Martin, M., Pienkowski, T., Mackey, J., Pawlicki, M., Guastalla, J.-P., Weaver, C., Tomiak, E., Al-Tweigeri, T., Chap, L., Juhos, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043681 · Cited by 954
Socinski, M. A., Bondarenko, I., Karaseva, N. A., Makhson, A. M., Vynnychenko, I., Okamoto, I., Hon, J. K., Hirsh, V., Bhar, P., Zhang, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5848 · Cited by 756
Mamounas, E. P., Bryant, J., Lembersky, B., Fehrenbacher, L., Sedlacek, S. M., Fisher, B., Wickerham, D. L., Yothers, G., Soran, A., & Wolmark, N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.517 · Cited by 714
Ibrahim, N. K., Desai, N. P., Legha, S. S., Soon‐Shiong, P., Theriault, R. L., Rivera, E., Esmaeli, B., Ring, S. E., Bedikian, A. Y., Hortobágyi, G. N., et al. (2002) · PubMed · Cited by 705
Seidman, A. D., Berry, D., Cirrincione, C., Harris, L., Muss, H., Marcom, P. K., Gipson, G., Burstein, H., Lake, D., Shapiro, C. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6699 · Cited by 594
Pharmacological Effects of Formulation Vehicles: Implications for Cancer Chemotherapy
ten Tije, A. J., Verweij, J., Loos, W. J., & Sparreboom, A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342070-00005 · Cited by 591
Bonomi, P., Kim, K., Fairclough, D., Cella, D., Kugler, J., Rowinsky, E., Jiroutek, M., & Johnson, D. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.623 · Cited by 589
Gianni, L., Kearns, C. M., Giani, A., Capri, G., Viganó, L., Lacatelli, A., Bonadonna, G., & Egorin, M. J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.180 · Cited by 553
Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer
Jones, S. E., Erban, J., Overmoyer, B., Budd, G. T., Hutchins, L., Lower, E., Laufman, L., Sundaram, S., Urba, W. J., Pritchard, K. I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.027 · Cited by 547
Nabholtz, J.-M., Senn, H. J., Bezwoda, W. R., Melnychuk, D., Deschênes, L., Douma, J., Vandenberg, T. A., Rapoport, B., Rosso, R., Trillet-Lenoir, V., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1413 · Cited by 508
Sparreboom, A., Scripture, C. D., Trieu, V., Williams, P. J., De, T., Yang, A., Beals, B., Figg, W. D., Hawkins, M., & Desai, N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2291 · Cited by 504
Sawada, N., Ishikawa, T., Fukase, Y., Nishida, M., Yoshikubo, T., & Ishitsuka, H. (1998) · PubMed · Cited by 422
Frese, K. K., Neesse, A., Cook, N., Bapiro, T. E., Lolkema, M. P., Jodrell, D. I., & Tuveson, D. A. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0242 · Cited by 415
Infante, J. R., Matsubayashi, H., Sato, N., Tonascia, J., Klein, A. P., Riall, T. A., Yeo, C., Iacobuzio-Donahue, C., & Goggins, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8824 · Cited by 406
Desai, N., Trieu, V., Damascelli, B., & Soon-Shiong, P. (2009) · Translational Oncology · doi:10.1593/tlo.09109 · Cited by 396
Nabholtz, J. M., Gelmon, K., Bontenbal, M., Spielmann, M., Catimel, G., Conte, P., Klaassen, U., Namer, M., Bonneterre, J., Fumoleau, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1858 · Cited by 380
Gradishar, W. J., Krasnojon, D., Cheporov, S., Makhson, A. N., Manikhas, G. M., Clawson, A., & Bhar, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5397 · Cited by 341
(1999) · PubMed · Cited by 337
Ishikawa, T., Utoh, M., Sawada, N., Nishida, M., Fukase, Y., Sekiguchi, F., & Ishitsuka, H. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00682-5 · Cited by 325
Stehle, G., Sinn, H., Wunder, A., Schrenk, H. H., Stewart, J. C. M., Hartung, G., Maier-Borst, W., & Heene, D. L. (1997) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(97)00015-2 · Cited by 305
Nyman, D. W., Campbell, K. J., Hersh, E., Long, K., Richardson, K., Trieu, V., Desai, N., Hawkins, M. J., & Von Hoff, D. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6148 · Cited by 286
Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer
John, T. A., Vogel, S. M., Tiruppathi, C., Malik, A. B., & Minshall, R. D. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00152.2002 · Cited by 269
Podhajcer, O. L., Benedetti, L. G., Girotti, M. R., Prada, F., Salvatierra, E., & Llera, A. S. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9146-7 · Cited by 236
Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab -Paclitaxel
Gardner, E. R., Dahut, W. L., Scripture, C. D., Jones, J., Aragon-Ching, J. B., Desai, N., Hawkins, M. J., Sparreboom, A., & Figg, W. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4592 · Cited by 226
Koukourakis, M. I., Giatromanolaki, A. N., Brekken, R. A., Sivridis, E., Gatter, K. C., Harris, A. L., & Sage, E. H. (2003) · PubMed · Cited by 220
Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients
Tellingen, O. V., Huizing, M. T., Panday, V. R. N., Schellens, J. H. M., Nooijen, W. J., & Beijnen, J. H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690696 · Cited by 211
Long, B. H., & Fairchild, C. R. (1994) · PubMed · Cited by 209
Distribution of SPARC in normal and neoplastic human tissue.
Porter, P. L., Sage, E. H., Lane, T. F., Funk, S. E., & Gown, A. M. (1995) · Journal of Histochemistry & Cytochemistry · doi:10.1177/43.8.7622842 · Cited by 209
Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey
Simionescu, M., Gafencu, A., & Antohe, F. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10086 · Cited by 207
Differential expression of osteonectin/SPARC during human prostate cancer progression.
Thomas, R., True, L. D., Bassuk, J. A., Lange, P. H., & Vessella, R. L. (2000) · PubMed · Cited by 196
Cortés, J., & Saura, C. (2010) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(10)70002-1 · Cited by 161
Taxol: a history of pharmaceutical development and current pharmaceutical concerns.
Adams, J. D., Flora, K. P., Goldspiel, B. R., Wilson, J., Arbuck, S. G., & Finley, R. W. (1993) · PubMed · Cited by 157
Sova, P., Feng, Q., Geiss, G. K., Wood, T., Strauss, R., Rudolf, V. P., Lieber, A., & Kiviat, N. B. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0323 · Cited by 150
Watkins, G., Douglas-Jones, A. G., Bryce, R. P., Mansel, R. E., & Jiang, W. G. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.12.003 · Cited by 146
Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas
Massi, D., Franchi, A., Borgognoni, L., Reali, U. M., & Santucci, M. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90014-x · Cited by 144
Rempel, S. A., Golembieski, W., Ge, S., et al. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199812000-00002 · Cited by 128
Hersh, E. M., O'Day, S. J., Ribas, A., Samlowski, W. E., Gordon, M. S., Shechter, D. E., Clawson, A., & Gonzalez, R. C. (2009) · Cancer · doi:10.1002/cncr.24720 · Cited by 119
Mauri, D. N., Kamposioras, K. V., Tsali, L., Bristianou, M., Valachis, A., Karathanasi, I., Georgiou, C., & Polyzos, N. P. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.10.006 · Cited by 116
ANALYSIS OF THE GENE EXPRESSION OF SPARC AND ITS PROGNOSTIC VALUE FOR BLADDER CANCER
Yamanaka, M., Kanda, K., Li, N.-C., Fukumori, T., Oka, N., Kanayama, H., & Kagawa, S. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65623-6 · Cited by 103
Pen, A., Moreno, M., Martin, J., et al. (2007) · Glia · doi:10.1002/glia.20481 · Cited by 101
Measurement of Fraction Unbound Paclitaxel in Human Plasma
Brouwer, E., Verweij, J., De Bruijn, P., Loos, W. J., Pillay, M., Buijs, D., & Sparreboom, A. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0026-895x(24)12040-8 · Cited by 98
Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein.
Kumar, G. N., Walle, U. K., Bhalla, K. N., & Walle, T. (1993) · PubMed · Cited by 98
SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma
Lau, C., Poon, R., Cheung, S., Yu, W., & Fan, S. (2006) · The Journal of Pathology · doi:10.1002/path.2068 · Cited by 82
Comparative Pharmacokinetics of Unbound Paclitaxel During 1- and 3-Hour Infusions
Gelderblom, H. A. J., Mross, K., ten Tije, A. J., Behringer, D. M., Mielke, S., van Zomeren, D. M., Verweij, J., & Sparreboom, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.574 · Cited by 82
Yamashita, K., Upadhay, S., Mimori, K., Inoue, H., & Mori, M. (2003) · Cancer · doi:10.1002/cncr.11368 · Cited by 78
Kato, Y., Nagashima, Y., Baba, Y., et al. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.16.2.263 · Cited by 37
Cited by
Controlled drug delivery vehicles for cancer treatment and their performance
Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167
Targeting drugs to tumours using cell membrane-coated nanoparticles
Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 688
Dawidczyk, C. M., Kim, C., Park, J. H., Russell, L. M., Lee, K. H., Pomper, M. G., & Searson, P. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.036 · Cited by 527
Talelli, M., Barz, M., Rijcken, C. J. F., Kiessling, F., Hennink, W. E., & Lammers, T. (2015) · Nano Today · doi:10.1016/j.nantod.2015.01.005 · Cited by 506
Metadata
- Authors
- Yardley, D. A.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 170
- Issue
- 3
- Pages
- 365-372
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2023250799
- Cited by
- 508
- References
- 59
- FWCI
- 13.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.